Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
Abstract Background Juvenile idiopathic arthritis (JIA) is common and difficult to treat. Cannabidiol (CBD) is now widely available, but no studies to date have investigated the use of CBD for JIA. Methods We performed a chart review to identify patients with JIA at a Midwestern medical institution...
Saved in:
Main Authors: | Christopher J Failing (Author), Kevin F. Boehnke (Author), Meredith Riebschleger (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis
by: Anjali Sura, et al.
Published: (2018) -
The use of cannabidiol (CBD) as an analgesic component
by: Kristian Kjær-Staal Petersen, et al.
Published: (2023) -
Efficacy of non-steroidal anti-inflammatory drug monotherapy in children with systemic juvenile idiopathic arthritis
by: Riebschleger Meredith P, et al.
Published: (2012) -
Towards Better Delivery of Cannabidiol (CBD)
by: Sophie Anne Millar, et al.
Published: (2020) -
Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans
by: Rachel S. Bergmans, et al.
Published: (2024)